{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:06:58Z","timestamp":1780340818799,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24 AG072122"],"award-info":[{"award-number":["U24 AG072122"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tjpad.2026.100555","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T10:28:25Z","timestamp":1776076105000},"page":"100555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypolipidemics reduce the rate of Alzheimer's disease development and dementia progression: A cohort study linked with genetic and neuropathological analyses"],"prefix":"10.1016","volume":"13","author":[{"given":"Zohi","family":"Sternberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Podolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihnhee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangcheng","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2430-4610","authenticated-orcid":false,"given":"Stanley","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard J.","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tjpad.2026.100555_bib0001","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.tjpad.2026.100555_bib0002","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100555_bib0003","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/NDT.S2154","article-title":"Strategies for molecular imaging dementia and neurodegenerative diseases","volume":"4","author":"Schaller","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100555_bib0004","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00259-003-1202-5","article-title":"PET-based molecular imaging in neuroscience","volume":"30","author":"Jacobs","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100555_bib0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"issue":"12","key":"10.1016\/j.tjpad.2026.100555_bib0006","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch Neurol"},{"issue":"2 Dementia","key":"10.1016\/j.tjpad.2026.100555_bib0007","first-page":"419","article-title":"Alzheimer Disease","volume":"22","author":"Apostolova","year":"2016","journal-title":"Contin (Minneap Minn)"},{"issue":"16","key":"10.1016\/j.tjpad.2026.100555_bib0008","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jama.1995.03520400044042","article-title":"Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals","volume":"273","author":"Petersen","year":"1995","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100555_bib0009","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","article-title":"Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype","volume":"15","author":"Vermunt","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.tjpad.2026.100555_bib0010","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1474-4422(17)30284-3","article-title":"Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study","volume":"16","author":"Josephs","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100555_bib0011","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1447-0594.2012.00934.x","article-title":"Rate of progression of Alzheimer's disease in younger versus older patients: a longitudinal single photon emission computed tomography study","volume":"13","author":"Sakai","year":"2013","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100555_bib0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/cns.12317","article-title":"Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease","volume":"21","author":"Peng","year":"2015","journal-title":"CNS Neurosci Ther"},{"issue":"524","key":"10.1016\/j.tjpad.2026.100555_bib0013","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5732","article-title":"Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET","volume":"12","author":"La Joie","year":"2020","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100555_bib0014","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/00325481.2019.1657776","article-title":"Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline","volume":"131","author":"Wanleenuwat","year":"2019","journal-title":"Postgr Med"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100555_bib0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.14283\/jpad.2022.73","article-title":"Delayed decline of cognitive function by antihypertensive agents: a cohort study linked with genotype data","volume":"9","author":"Sternberg","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100555_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002265","article-title":"Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C study: a longitudinal, population-based prospective cohort study","volume":"14","author":"Schilling","year":"2017","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100555_bib0017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-160826","article-title":"Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis","volume":"56","author":"Anstey","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.tjpad.2026.100555_bib0018","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archinte.163.9.1053","article-title":"Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study","volume":"163","author":"Tan","year":"2003","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100555_bib0019","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3945\/ajcn.116.146753","article-title":"Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study","volume":"105","author":"Ylilauri","year":"2017","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100555_bib0020","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3233\/JAD-210122","article-title":"A high fat\/cholesterol diet recapitulates some Alzheimer's disease-like features in mice: focus on hippocampal mitochondrial dysfunction","volume":"82","author":"Mancini","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2026.100555_bib0021","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2016.06.012","article-title":"Detrimental effects of a high fat\/high cholesterol diet on memory and hippocampal markers in aged rats","volume":"312","author":"Ledreux","year":"2016","journal-title":"Behav Brain Res"},{"issue":"23-24","key":"10.1016\/j.tjpad.2026.100555_bib0022","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.lfs.2011.12.022","article-title":"Hypercholesterolemia accelerates intraneuronal accumulation of Abeta oligomers resulting in memory impairment in Alzheimer's disease model mice","volume":"91","author":"Umeda","year":"2012","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100555_bib0023","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3233\/JAD-2012-121030","article-title":"Increased tau phosphorylation and impaired brain insulin\/IGF signaling in mice fed a high fat\/high cholesterol diet","volume":"36","author":"Bhat","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100555_bib0024","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3233\/JAD-191023","article-title":"Association of hypercholesterolemia with Alzheimer's Disease pathology and cerebral amyloid angiopathy","volume":"73","author":"Xu","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100555_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.18865\/ed.25.3.345","article-title":"Statin use, incident dementia and Alzheimer disease in elderly African Americans","volume":"25","author":"Hendrie","year":"2015","journal-title":"Ethn Dis"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100555_bib0026","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/joim.13134","article-title":"Statin exposure and the risk of dementia in individuals with hypercholesterolaemia","volume":"288","author":"Lee","year":"2020","journal-title":"J Intern Med"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100555_bib0027","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209168","article-title":"Statin initiation and risk of incident Alzheimer disease and cognitive decline in genetically susceptible older adults","volume":"102","author":"Rajan","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2026.100555_bib0028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2023.10.005","article-title":"Metformin, age-related cognitive decline, and brain pathology","volume":"133","author":"Sood","year":"2024","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100555_bib0029","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11065-018-9388-2","article-title":"Cognitive Deficits in psychotic disorders: a lifespan perspective","volume":"28","author":"Sheffield","year":"2018","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.tjpad.2026.100555_bib0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inf Decis Mak"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100555_bib0031","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurjpc\/zwab208","article-title":"Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies","volume":"29","author":"Olmastroni","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.tjpad.2026.100555_bib0032","article-title":"Cognitive function in dyslipidemia patients: exploring the impact of statins","volume":"15","author":"Wang","year":"2024","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100555_bib0033","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13195-023-01360-0","article-title":"Statins and cognitive decline in patients with Alzheimer's and mixed dementia: a longitudinal registry-based cohort study","volume":"15","author":"Petek","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100555_bib0034","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1038\/s41598-020-63035-2","article-title":"The cognitive effects of statins are modified by age","volume":"10","author":"Alsehli","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100555_bib0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/clc.22361","article-title":"Cholesterol, statins, and dementia: what the cardiologist should know","volume":"38","author":"Wanamaker","year":"2015","journal-title":"Clin Cardiol"},{"issue":"9346","key":"10.1016\/j.tjpad.2026.100555_bib0036","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tjpad.2026.100555_bib0037","article-title":"Hypercholesterolemia accelerates a\u03b2 deposition in regions associated with early amyloidosis: neuroimaging\/optimal neuroimaging measures for tracking disease progression","volume":"16","author":"Souza","year":"2020","journal-title":"Alzheimer\u2019s Demen J"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100555_bib0038","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-150734","article-title":"Cholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol as surrogate biomarkers in cerebrospinal fluid in mild cognitive impairment and Alzheimer's Disease: a meta-analysis","volume":"51","author":"Wang","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100555_bib0039","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bpa.12698","article-title":"27-hydroxycholesterol promotes Abeta accumulation via altering Abeta metabolism in mild cognitive impairment patients and APP\/PS1 mice","volume":"29","author":"Zhang","year":"2019","journal-title":"Brain Pathol"},{"key":"10.1016\/j.tjpad.2026.100555_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41514-025-00303-3","article-title":"27-Hydroxycholesterol triggers microglial senescence subsequent to iron over-loading contributes to brain aging, suppressed by Deferoxamine","author":"Yu","year":"2025","journal-title":"NPJ Aging"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100555_bib0041","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13195-023-01342-2","article-title":"Distinct effects of cholesterol profile components on amyloid and vascular burdens","volume":"15","author":"Kang","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100555_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285529","article-title":"N.s. group, what is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?","volume":"18","author":"Murphy","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100555_bib0043","doi-asserted-by":"crossref","first-page":"fcae031","DOI":"10.1093\/braincomms\/fcae031","article-title":"Tau accumulation and its spatial progression across the Alzheimer's disease spectrum","volume":"6","author":"St-Onge","year":"2024","journal-title":"Brain Commun"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100555_bib0044","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2967\/jnumed.122.265200","article-title":"The use of tau PET to stage Alzheimer disease according to the Braak Staging Framework","volume":"64","author":"Macedo","year":"2023","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.tjpad.2026.100555_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70831","article-title":"Tau mediates the impact of amyloid and vascular disease burden on the trajectory of clinical symptoms","volume":"21","author":"Du","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100555_bib0046","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13760-025-02758-3","article-title":"Statins and the risk of dementia: a meta-analysis","volume":"125","author":"Li","year":"2025","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.tjpad.2026.100555_bib0047","series-title":"Neuroprotective effects of statins and cyclodextrins: review and potential role in dementia treatment","author":"Qutub Jamali","year":"2025"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100555_bib0048","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afaf219","article-title":"Association of lipid-lowering therapy with dementia and cognitive outcomes: a systematic review and meta-analysis","volume":"54","author":"Reddin","year":"2025","journal-title":"Age Ageing"},{"issue":"10","key":"10.1016\/j.tjpad.2026.100555_bib0049","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jnnp-2024-334708","article-title":"Low-density lipoprotein cholesterol levels and risk of incident dementia: a distributed network analysis using common data models","volume":"96","author":"Lee","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:42:39Z","timestamp":1780339359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2274580726000798"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100555","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypolipidemics reduce the rate of Alzheimer's disease development and dementia progression: A cohort study linked with genetic and neuropathological analyses","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100555"}}